Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Boxer

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
The Journal of Biological Chemistry|August 1, 1997
The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomasC Heckman, E Mochon, M Arcinas, et al.
The Journal of Biological Chemistry|January 15, 1989
Identification and characterization of a factor that binds to two human sarcomeric actin promotersL M Boxer, T Miwa, T A Gustafson, et al.
Molecular and Cellular Biology|October 1, 1988
Interaction of nuclear proteins with muscle-specific regulatory sequences of the human cardiac alpha-actin promoterT A Gustafson, T Miwa, L M Boxer, et al.
Molecular and Cellular Biology|May 1, 1996
Identification of an inducible regulator of c-myb expression during T-cell activationS C Phan, B Feeley, D Withers, et al.
Leukemia|February 9, 2007
Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancerH-M Hu, K Kanda, L Zhang, et al.
Molecular and Cellular Biology|February 1, 1989
The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factorL M Boxer, R Prywes, R G Roeder, et al.
Oncogene|September 28, 2005
Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expressionC A Heckman, H Duan, P B Garcia, et al.
Cancer Research|June 30, 2001
Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphomaM Arcinas, C A Heckman, J W Mehew, et al.
The Journal of Biological Chemistry|October 6, 1995
Repression of the c-myb gene by WT1 protein in T and B cell linesS McCann, J Sullivan, J Guerra, et al.
The Journal of Biological Chemistry|August 10, 2000
NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancerK Kanda, H M Hu, L Zhang, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
The Journal of Biological Chemistry|August 1, 1997
The WT1 protein is a negative regulator of the normal bcl-2 allele in t(14;18) lymphomasC Heckman, E Mochon, M Arcinas, et al.
The Journal of Biological Chemistry|January 15, 1989
Identification and characterization of a factor that binds to two human sarcomeric actin promotersL M Boxer, T Miwa, T A Gustafson, et al.
Molecular and Cellular Biology|October 1, 1988
Interaction of nuclear proteins with muscle-specific regulatory sequences of the human cardiac alpha-actin promoterT A Gustafson, T Miwa, L M Boxer, et al.
Molecular and Cellular Biology|May 1, 1996
Identification of an inducible regulator of c-myb expression during T-cell activationS C Phan, B Feeley, D Withers, et al.
Leukemia|February 9, 2007
Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancerH-M Hu, K Kanda, L Zhang, et al.
Molecular and Cellular Biology|February 1, 1989
The sarcomeric actin CArG-binding factor is indistinguishable from the c-fos serum response factorL M Boxer, R Prywes, R G Roeder, et al.
Oncogene|September 28, 2005
Oct transcription factors mediate t(14;18) lymphoma cell survival by directly regulating bcl-2 expressionC A Heckman, H Duan, P B Garcia, et al.
Cancer Research|June 30, 2001
Molecular mechanisms of transcriptional control of bcl-2 and c-myc in follicular and transformed lymphomaM Arcinas, C A Heckman, J W Mehew, et al.
The Journal of Biological Chemistry|October 6, 1995
Repression of the c-myb gene by WT1 protein in T and B cell linesS McCann, J Sullivan, J Guerra, et al.
The Journal of Biological Chemistry|August 10, 2000
NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancerK Kanda, H M Hu, L Zhang, et al.
Pageof 5